Mapping pelvic lymph nodes: guidelines for delineation in intensity-modulated radiotherapy.
暂无分享,去创建一个
R. Reznek | A. Rockall | Alexandra Taylor | Andrea G Rockall | Rodney H Reznek | Melanie E B Powell | M. Powell | Alexandra Taylor
[1] J. Buatti,et al. Does prone positioning reduce small bowel dose in pelvic radiation with intensity-modulated radiotherapy for gynecologic cancer? , 2003, International journal of radiation oncology, biology, physics.
[2] P. Koper,et al. The morbidity of treatment for patients with stage I endometrial cancer: results from a randomized trial , 2002 .
[3] John C Roeske,et al. Preliminary analysis of chronic gastrointestinal toxicity in gynecology patients treated with intensity-modulated whole pelvic radiation therapy. , 2003, International journal of radiation oncology, biology, physics.
[4] M R Segal,et al. Radiological evaluation of lymph node metastases in patients with cervical cancer. A meta-analysis. , 1997, JAMA.
[5] B. Corn,et al. Bony landmarks are not an adequate substitute for lymphangiography in defining pelvic lymph node location for the treatment of cervical cancer with radiotherapy. , 1996, International journal of radiation oncology, biology, physics.
[6] D. Koh,et al. Rectal cancer: mesorectal lymph nodes at MR imaging with USPIO versus histopathologic findings--initial observations. , 2004, Radiology.
[7] B. Marincek,et al. USPIO-enhanced MRI for preoperative staging of gynecological pelvic tumors: preliminary results , 2004, European Radiology.
[8] J Williamson,et al. Radiation therapy morbidity in carcinoma of the uterine cervix: dosimetric and clinical correlation. , 1999, International journal of radiation oncology, biology, physics.
[9] D P Dearnaley,et al. Reduction of small and large bowel irradiation using an optimized intensity-modulated pelvic radiotherapy technique in patients with prostate cancer. , 2000, International journal of radiation oncology, biology, physics.
[10] N. Sakuragi,et al. Incidence and distribution pattern of pelvic and paraaortic lymph node metastasis in patients with stages IB, IIA, and IIB cervical carcinoma treated with radical hysterectomy , 1999, Cancer.
[11] S. Way,et al. OBSERVATIONS ON LYMPH NODE INVOLVEMENT IN CARCINOMA OF THE CERVIX , 1953 .
[12] John C Roeske,et al. Intensity-modulated whole pelvic radiotherapy in women with gynecologic malignancies. , 2002, International journal of radiation oncology, biology, physics.
[13] E. Henriksen. The lymphatic spread of carcinoma of the cervix and of the body of the uterus; a study of 420 necropsies. , 1949, American journal of obstetrics and gynecology.
[14] J. Tierney,et al. A systematic review of acute and late toxicity of concomitant chemoradiation for cervical cancer. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[15] J. Cain,et al. Gynecologic radiotherapy fields defined by intraoperative measurements. , 1990, Gynecologic oncology.
[16] D Low,et al. Intensity-modulated radiation therapy (IMRT) reduces small bowel, rectum, and bladder doses in patients with cervical cancer receiving pelvic and para-aortic irradiation. , 2001, International journal of radiation oncology, biology, physics.
[17] K. Eichler,et al. Superparamagnetic iron oxide-enhanced MR imaging of head and neck lymph nodes. , 2002, Radiology.
[18] A. Norman,et al. MR evaluation of normal retroperitoneal and pelvic lymph nodes. , 2002, Clinical radiology.
[19] G. Marchal,et al. Lymph node metastases from head and neck squamous cell carcinoma: MR imaging with ultrasmall superparamagnetic iron oxide particles (Sinerem MR) – results of a phase-III multicenter clinical trial , 2002, European Radiology.
[20] M. Harisinghani,et al. Diagnostic performance of nanoparticle-enhanced magnetic resonance imaging in the diagnosis of lymph node metastases in patients with endometrial and cervical cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] G. Scambia,et al. Lymphatic spread of cervical cancer: an anatomical and pathological study based on 225 radical hysterectomies with systematic pelvic and aortic lymphadenectomy. , 1996, Gynecologic oncology.
[22] Chun-Chieh Wang,et al. Recurrent squamous cell carcinoma of cervix after definitive radiotherapy. , 2004, International journal of radiation oncology, biology, physics.
[23] A. Norman,et al. Normal pelvic lymph nodes: evaluation with CT after bipedal lymphangiography. , 1995, Radiology.
[24] J. Mcivor. Changes in lymph node size induced by lymphography. , 1980, Clinical radiology.
[25] K. Chao,et al. Lymphangiogram-assisted lymph node target delineation for patients with gynecologic malignancies. , 2002, International journal of radiation oncology, biology, physics.
[26] J. Roeske,et al. Intensity-modulated whole pelvic radiation therapy in patients with gynecologic malignancies. , 2000, International journal of radiation oncology, biology, physics.
[27] S. Pendlebury,et al. Role of bipedal lymphangiogram in radiation treatment planning for cervix cancer. , 1993, International journal of radiation oncology, biology, physics.
[28] H. Pannu,et al. MR imaging of mediastinal lymph nodes: Evaluation using a superparamagnetic contrast agent , 2000, Journal of magnetic resonance imaging : JMRI.
[29] Patrick M M Bossuyt,et al. Computed tomography and magnetic resonance imaging in staging of uterine cervical carcinoma: a systematic review. , 2003, Gynecologic oncology.
[30] N. deSouza,et al. Detection of pelvic lymph node metastases in gynecologic malignancy: a comparison of CT, MR imaging, and positron emission tomography. , 2001, AJR. American journal of roentgenology.
[31] S. Kalnicki,et al. Conventional 3D conformal versus intensity-modulated radiotherapy for the adjuvant treatment of gynecologic malignancies: a comparative dosimetric study of dose-volume histograms. , 2003, Gynecologic oncology.